Publication | Closed Access

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

Higher DosesTransplantationMarrow TransplantationAutoimmune DiseaseIncreased MortalityStem Cell TransplantationImmunologyHematologyChronic Graft-versus-host DiseaseAutoimmunityGraft SurvivalCell TransplantationBlood TransplantationMedicineCell BiologyGraft Rejection